Ramani Vinod K, V Ganesha D, Benny Neethu, Naik Radheshyam
Healthcare Global Enterprise Ltd., Bangalore, India.
Department of Medical Oncology, St.John's Medical College and Hospital, Bangalore, India.
Tob Use Insights. 2021 Oct 26;14:1179173X211050395. doi: 10.1177/1179173X211050395. eCollection 2021.
Cancer patients commonly present with antecedent addiction to tobacco consumption. Our study describes the characteristics of this substance use. Following the diagnosis of cancer, continued consumption of tobacco results in reduced tolerance to treatment, failure of treatment, tumor progression, other primary tumors, secondary cancers, and poor quality of life. The aim of our study is to enumerate the clinico-social aspects of tobacco consumption among cancer patients.
This cross-sectional study includes 100 cancer patients admitted to Healthcare Global cancer hospital, Bangalore, India. The study subjects were assessed for tobacco consumption, as well as other substance use such as intake of alcohol. We assessed various dimensions of exposure to tobacco consumption such as duration, intensity, and cumulative dose as independent risk factors for cancer.
Among the study subjects, 46.2% were found to smoke filter cigarettes. The mean duration of tobacco consumption among beedi users was found to be longer (25.9 years, SD: 14.4). When stratified for exclusive consumption, the mean durations were as follows: beedis (29 ± 14.4 years), cigarettes (23.8 ± 13.3 years), and chewing (15.9 ± 9.6 years). Along with tobacco, a large proportion (59.3%) of patients consumed alcohol as well. After attempts to quit, 89.01% patients had reversal of tobacco substance use. The data did not show significance for duration, intensity, and cumulative dose of tobacco consumption.
The diagnosis of cancer is a life-altering event, which results in higher motivation to quit the use of tobacco. Smoking cessation initiatives can reduce the risk of developing tobacco-related malignancies.
癌症患者通常之前就有吸烟成瘾的情况。我们的研究描述了这种物质使用的特征。在癌症诊断之后，继续吸烟会导致对治疗的耐受性降低、治疗失败、肿瘤进展、出现其他原发性肿瘤、继发性癌症以及生活质量下降。我们研究的目的是列举癌症患者吸烟的临床社会方面情况。
这项横断面研究纳入了印度班加罗尔医疗全球癌症医院收治的100例癌症患者。对研究对象进行了吸烟情况以及其他物质使用情况（如饮酒）的评估。我们评估了吸烟的各个暴露维度，如持续时间、强度和累积剂量，将其作为癌症的独立危险因素。
在研究对象中，发现46.2%的人吸过滤嘴香烟。发现比迪烟使用者的平均吸烟持续时间更长（25.9年，标准差：14.4）。按单纯使用情况分层时，平均持续时间如下：比迪烟（29±14.4年）、香烟（23.8±13.3年）和咀嚼烟草（15.9±9.6年）。除了吸烟，很大一部分患者（59.3%）也饮酒。在尝试戒烟后，89.01%的患者恢复了吸烟。数据未显示吸烟的持续时间、强度和累积剂量有显著意义。
癌症诊断是改变生活的事件，会使戒烟的动机增强。戒烟举措可降低发生烟草相关恶性肿瘤的风险。
